Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA.

Bétemps D, Verchère J, Brot S, Morignat E, Bousset L, Gaillard D, Lakhdar L, Melki R, Baron T.

Acta Neuropathol Commun · 2014-03-13

DOI: 10.1186/2051-5960-2-29PMID: 24624994

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity.

O'Donnell KC, Lulla A, Stahl MC, Wheat ND, Bronstein JM, Sagasti A.

Dis Model Mech · 2014-03-13

DOI: 10.1242/dmm.013185PMID: 24626988

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Sequestration of a β-hairpin for control of α-synuclein aggregation.

Mirecka EA, Shaykhalishahi H, Gauhar A, Akgül Ş, Lecher J, Willbold D, Stoldt M, Hoyer W.

Angew Chem Int Ed Engl · 2014-03-12

DOI: 10.1002/anie.201309001PMID: 24623599

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

No association between genetic variants of the LRRK2 gene and schizophrenia in Han Chinese.

Li X, Zhang W, Zhang C, Gong W, Tang J, Yi Z, Wang D, Lu W, Fang Y, Chen X, Yao YG.

Neurosci Lett · 2014-03-12

DOI: 10.1016/j.neulet.2014.03.006PMID: 24631561

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

Stewart T, Liu C, Ginghina C, Cain KC, Auinger P, Cholerton B, Shi M, Zhang J, Parkinson Study Group DATATOP Investigators.

Am J Pathol · 2014-03-11

DOI: 10.1016/j.ajpath.2013.12.007PMID: 24625392

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.

Diepenbroek M, Casadei N, Esmer H, Saido TC, Takano J, Kahle PJ, Nixon RA, Rao MV, Melki R, Pieri L, Helling S, Marcus K, Krueger R, Masliah E, Riess O, Nuber S.

Hum Mol Genet · 2014-03-11

DOI: 10.1093/hmg/ddu112PMID: 24619358

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Does uncoupling protein 2 expression qualify as marker of disease status in LRRK2-associated Parkinson's disease?

Grünewald A, Arns B, Meier B, Brockmann K, Tadic V, Klein C.

Antioxid Redox Signal · 2014-03-07

DOI: 10.1089/ars.2013.5737PMID: 24251413

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.

Kong SM, Chan BK, Park JS, Hill KJ, Aitken JB, Cottle L, Farghaian H, Cole AR, Lay PA, Sue CM, Cooper AA.

Hum Mol Genet · 2014-03-06

DOI: 10.1093/hmg/ddu099PMID: 24603074

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

δ-Opioid receptor activation reduces α-synuclein overexpression and oligomer formation induced by MPP(+) and/or hypoxia.

Chen T, Li J, Chao D, Sandhu HK, Liao X, Zhao J, Wen G, Xia Y.

Exp Neurol · 2014-03-05

DOI: 10.1016/j.expneurol.2014.02.022PMID: 24613828

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Markopoulou K, Biernacka JM, Armasu SM, Anderson KJ, Ahlskog JE, Chase BA, Chung SJ, Cunningham JM, Farrer M, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord · 2014-03-05

DOI: 10.1016/j.parkreldis.2014.02.021PMID: 24656894

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease.

Shannon B, Soto-Ortolaza A, Rayaprolu S, Cannon HD, Labbé C, Benitez BA, Choi J, Lynch T, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Van Gerpen JA, Uitti RJ, Springer W, Cruchaga C, Wszolek ZK, Ross OA.

Neurobiol Aging · 2014-03-05

DOI: 10.1016/j.neurobiolaging.2014.03.004PMID: 24684791

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity.

Liu HF, Lu S, Ho PW, Tse HM, Pang SY, Kung MH, Ho JW, Ramsden DB, Zhou ZJ, Ho SL.

Ann Clin Transl Neurol · 2014-03-04

DOI: 10.1002/acn3.45PMID: 25356398

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

9.897 makale bulundu

Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA.

Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity.

Sequestration of a β-hairpin for control of α-synuclein aggregation.

No association between genetic variants of the LRRK2 gene and schizophrenia in Han Chinese.

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.

Does uncoupling protein 2 expression qualify as marker of disease status in LRRK2-associated Parkinson's disease?

Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.

δ-Opioid receptor activation reduces α-synuclein overexpression and oligomer formation induced by MPP(+) and/or hypoxia.

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease.

LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity.

Filtreler